Showing results (271-280 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|April 23, 2021
High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterationsYiwei Liu, Wanying Wang, Fengying Wu, et al.
Translational Lung Cancer Research|May 17, 2023
Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targetsMidori Shimada, Hirokazu Taniguchi, Hiroyuki Yamaguchi, et al.
Translational Lung Cancer Research|May 17, 2023
Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectivesMark G Kris, Tetsuya Mitsudomi, Solange Peters
Translational Lung Cancer Research|May 17, 2023
Activity of osimertinib in a patient with stage IV non-small cell lung cancer harboring HER2 exon 19, p.L755P mutation: case reportGudbjorg Jonsdottir, Mark Smith, Samuel Wood, et al.
Translational Lung Cancer Research|May 17, 2023
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancerJeong Uk Lim, Eunyoung Lee, Sang-Yun Lee, et al.
Translational Lung Cancer Research|July 18, 2020
18F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancerDiego M Avella, Yariswamy Manjunath, Amolak Singh, et al.
Translational Lung Cancer Research|July 18, 2020
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapyOlarn Roengvoraphoj, Lukas Käsmann, Chukwuka Eze, et al.
Translational Lung Cancer Research|July 18, 2020
Predicting EGFR mutation subtypes in lung adenocarcinoma using 18F-FDG PET/CT radiomic featuresQiufang Liu, Dazhen Sun, Nan Li, et al.
Translational Lung Cancer Research|July 18, 2020
Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinomaWeiquan Gu, Na Wang, Weiguang Gu, et al.
Translational Lung Cancer Research|July 18, 2020
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: a case reportRoberta Minari, Letizia Gnetti, Costanza Annamaria Lagrasta, et al.
Pageof 240